434 related articles for article (PubMed ID: 29273417)
1. An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Cherukupalli S; Hampannavar GA; Chinnam S; Chandrasekaran B; Sayyad N; Kayamba F; Reddy Aleti R; Karpoormath R
Bioorg Med Chem; 2018 Jan; 26(2):309-339. PubMed ID: 29273417
[TBL] [Abstract][Full Text] [Related]
2. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
Abdellatif KRA; Bakr RB
Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655
[TBL] [Abstract][Full Text] [Related]
3. Functional Pyrazolo[1,5-
Arias-Gómez A; Godoy A; Portilla J
Molecules; 2021 May; 26(9):. PubMed ID: 34063043
[TBL] [Abstract][Full Text] [Related]
4. An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Cherukupalli S; Karpoormath R; Chandrasekaran B; Hampannavar GA; Thapliyal N; Palakollu VN
Eur J Med Chem; 2017 Jan; 126():298-352. PubMed ID: 27894044
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
El-Sayed Ali T
Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
[TBL] [Abstract][Full Text] [Related]
6. An overview on synthetic and pharmaceutical prospective of pyrido[2,3-d]pyrimidines scaffold.
Yadav P; Shah K
Chem Biol Drug Des; 2021 Mar; 97(3):633-648. PubMed ID: 32946161
[TBL] [Abstract][Full Text] [Related]
7. Medicinal attributes of pyrazolo[3,4-d]pyrimidines: a review.
Chauhan M; Kumar R
Bioorg Med Chem; 2013 Sep; 21(18):5657-68. PubMed ID: 23932070
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
9. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Ali EMH; Abdel-Maksoud MS; Oh CH
Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents.
Holla BS; Mahalinga M; Karthikeyan MS; Akberali PM; Shetty NS
Bioorg Med Chem; 2006 Mar; 14(6):2040-7. PubMed ID: 16310361
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolo - Pyrimidines as Targeted Anticancer Scaffolds - A Comprehensive Review.
Kandhasamy K; Surajambika RR; Velayudham PK
Med Chem; 2024; 20(3):293-310. PubMed ID: 37885114
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.
Azam MA; Dharanya L; Mehta CC; Sachdeva S
Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310
[TBL] [Abstract][Full Text] [Related]
14. A facile and novel synthesis of N(2)-, C(6)-substituted pyrazolo[3,4-d]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists.
Venkatesan G; Paira P; Cheong SL; Federico S; Klotz KN; Spalluto G; Pastorin G
Eur J Med Chem; 2015 Mar; 92():784-98. PubMed ID: 25633494
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
Yuan L; Song C; Li C; Li Y; Dong L; Yin S
Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
[TBL] [Abstract][Full Text] [Related]
16. Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation.
Shamroukh AH; Rashad AE; Abdel-Megeid RE; Ali HS; Ali MM
Arch Pharm (Weinheim); 2014 Aug; 347(8):559-65. PubMed ID: 24801813
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anticancer evaluation of novel pyrazole, pyrazolo[3,4-d]pyrimidine and their glycoside derivatives.
Nassar IF; El Farargy AF; Abdelrazek FM; Ismail NSM
Nucleosides Nucleotides Nucleic Acids; 2017 Apr; 36(4):275-291. PubMed ID: 28323527
[TBL] [Abstract][Full Text] [Related]
18. Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic properties.
Ren L; Laird ER; Buckmelter AJ; Dinkel V; Gloor SL; Grina J; Newhouse B; Rasor K; Hastings G; Gradl SN; Rudolph J
Bioorg Med Chem Lett; 2012 Jan; 22(2):1165-8. PubMed ID: 22196124
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, In Vitro Antimicrobial and Cytotoxic Activities of Some New Pyrazolo[1,5-
Fouda AM; Abbas HS; Ahmed EH; Shati AA; Alfaifi MY; Elbehairi SEI
Molecules; 2019 Mar; 24(6):. PubMed ID: 30893820
[TBL] [Abstract][Full Text] [Related]
20. A convenient synthesis and molecular modeling study of novel pyrazolo[3,4-d]pyrimidine and pyrazole derivatives as anti-tumor agents.
Nassar IF; Atta-Allah SR; Elgazwy AS
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):396-405. PubMed ID: 25068728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
